A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02225912

Enrollment

Unknown

Registered

2014-08-26

Start date

2005-02-28

Completion date

2005-05-31

Last updated

2019-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Respiratory Infections

Brief summary

The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.

Interventions

OTHERPrevinC

DRUGplacebo

Study design

Intervention model

CROSSOVER

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Inclusion criteria

* Subject must provide written informed consent prior to the conduct of any study * Male or female * 18-65 years of age * Inclusive * Employed by one of seven selected Day Care Centers

Exclusion criteria

* Recent symptoms of upper respiratory infection, respiratory disease * Received medication for colds or allergies within 3 weeks of enrolling * Had nasal surgery within 2 months of enrolling * Had a pierced nose or wore nose jewelry

Design outcomes

Primary

Measure	Time frame	Description
Rhinitis	weekly from February 2005 to May 2005, up to 3 months	The incidence of rhinitis was measured on a weekly basis through evaluation of study diaries.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026